P&G Thinks Globally, Acts Locally With Long-Term Growth Strategy
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble has its eye on broadening its reach in key developing markets as it pursues its comprehensive global growth strategy
You may also be interested in...
Prilosec OTC Exceeds Sales Expectations, Drags Down Healthcare Earnings
Prilosec OTC sales have been a boon to Procter & Gamble's healthcare top line, but the product's successful launch has negatively impacted earnings a year after its debut
P&G Business Realignment Combines Healthcare With Baby, Family Units
Procter & Gamble will consolidate its health, baby and family care units as a single entity under new leadership as part of a strategic realignment announced May 19
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC